Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BTD is getting closer

<< Previous

Bullboard Posts

Next >>

Comment by thadeushon Nov 27, 2024 8:15pm

107 Views

Post# 36334809

RE:BTD is getting closer

Yes, and remember, all of these studies are on very difficult to treat BCG resistant patients. Just think what TLTs response rates will be when it becomes the standard of care for the NMIBC patients early in their diagnosis.

Q4 2024 and Q1 2025? This nr is absolutely fine with me :)

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season